Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 February, 2018 00:58 IST
Indoco Remedies gets 8 USFDA observations for its Goa unit
Source: IRIS | 14 Feb, 2018, 10.09AM
Comments  |  Post Comment

Indoco Remedies has informed that USFDA inspected its solid dosage plant in Goa (Unit I). At the end of the inspection, the plant has received 8 observations (483s). The filling indicates that all the observations are correctable and the company is in the process of preparing its response for the same.

Exports from Goa solid dosage plant constitute less than 10% of the Indoco’s total exports and less than 4% of the total sales.

Shares of the company declined Rs 6.45, or 2.33%, to trade at Rs 269.90. The total volume of shares traded was 7,323 at the BSE (9.59 a.m., Wednesday).





Indoco Remedies Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Lupin launches generic Namenda XR capsules in US - 21-Feb-2018 16:00
Home textiles exporters stare at 300 bps fall in profitability: Crisil - 21-Feb-2018 14:32
Lupin gets USFDA nod for generic Tamiflu for oral suspension - 21-Feb-2018 14:27
SSWL wins exports order from German OEM-BMW - 21-Feb-2018 12:15
BHEL bags Rs 10.34 bn captive power plant order - 21-Feb-2018 12:07
Reliance Ind to acquire 5% stake in Eros Int'l PLC - 21-Feb-2018 10:51
IRB Infra Developers receives appointed date for Kishangarh Gulabpura Tollway project - 21-Feb-2018 09:44
USFDA completes pre-approval inspection at Biocon Malyasia - 21-Feb-2018 09:31
Dilip Buildcon wins NHAI EPC project worth Rs 3.80 bn - 21-Feb-2018 09:28
CMI Energy bags order from Engineers India - 20-Feb-2018 14:27
Import duty, stock limits spell relief for sugar sector: Crisil - 20-Feb-2018 13:17
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer